A Single-Center, Double-blind, Random, Parallel Controlled Study
A Single-Center, Double-blind, Random, Parallel Controlled Study
The study hypothesis is that 3 Months Daily Supplementation of RGC will effect blood pressure and vascular function.
This will be a single-center, double-blind, random, parallel controlled Study. Study population will include 60 subjects, who will be divided randomly into three groups. The first group will get RGC 200mg, the second group will get RGC 400mg, and the third group will get 200mg placebo.
Inclusion Criteria:
Exclusion Criteria: